Navigation Links
Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL
Date:8/1/2014

Toledo, Ohio (PRWEB) August 01, 2014

The Judicial Panel on Multidistrict Litigation (JPML) issued an order consolidating claims that testosterone replacement therapy caused strokes, heart attacks, and other injuries in men who used it. The JPML designated Judge Matthew F. Kennelly as the transferee judge and ordered what could be thousands of cases transferred to the Chicago-based federal court.

As one of his first organizing acts, Judge Kennelly undertook the task of appointing committees of attorneys who will move the litigation forward on behalf of all claimants and attorneys nationwide. But, before designating the 34 attorneys who will lead the consolidated litigation, the Court interviewed each applicant in open court and each submitted detailed information about his or her level of experience, ability to commit the time and resources to this litigation, and ability to work with others in the group. Ms. Kranz listed a number of high-profile appointments to committees in similar litigations.

In choosing the 34 attorneys, Judge Kennelly noted that the group is larger than past multi-district litigation groups. But, he also observed this is not the typical MDL proceeding; there are six different defendants and multiple forms of the testosterone replacement therapy products.

  • Co-lead counsel: Ronald R. Johnson, Jr., Trent B. Miracle, and Christopher A. Seeger;
  • Executive Committee: Timothy Becker, Michael Papantonio, Seth Katz, Michael London, Maury A. Herman, Michelle Kranz, and Bill Robins;
  • Steering Committee: Martin Crump, T. Matthew Leckman, Lawrence J. Gornick, Matthew Teague, Gregory Spizer, Frank Petosa, Kristine Kraft, Elwood C. Stevens, Jr., Christopher Tisi, Arnold Levin, Alex H. MacDonald, Mark A. Hoffman, Dawn M. Barrios, Derriel C. McCorvey, Roger W. Orlando, Rachel Abrams, W. Mark Lanier, David S. Ratner,    Will Moody, Jr., Yvonne Flaherty, Dianne Nast, and Kathleen Chavez;
  • Co-Liaison Counsel: Brian J. Perkins and Myron Cherry

Zoll, Kranz & Borgess, LLC, an experienced pharmaceutical and medical device litigation firm, is currently investigating claims of individuals who were injured in result to the use of testosterone therapies, including AndroGel, Testim, Depo-Testosterone, AndroDerm, and Axiron.

Contact ZKB toll-free to find out more information on this litigation or ZKB at 888-841-9623 or http://www.zkblaw.com.

Source: MDL Case Management Order No. 4, Case No. 14 C 1748 of the United States District Court for the Northern District of Illinois.

Read the full story at http://www.prweb.com/releases/Attorney-Michelle-Kranz/Appointed-PEC-By-Judge/prweb12067213.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports
2. DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports
3. Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports
4. CCHR Applauds Judge for Upholding Detroit Mother Maryanne Godboldo’s Right to Protect Daughter from Forced Drugging
5. Mirena IUD Lawsuit Allowed to Proceed in State Court, After Judge Rules Certain Healthcare Defendants Weren’t Misjoined, Bernstein Liebhard LLP Reports
6. Federal Judge Overseeing Ethicon Vaginal Mesh Lawsuit Denies Summary Judgment on Certain Claims, Bernstein Liebhard LLP Reports
7. Dont Judge a Pill by Its Color
8. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
9. Dont judge older drivers by age: QUT study
10. Federal Judge Orders Review of C.R. Bard Avaulta Vaginal Mesh Lawsuits, Rottenstein Law Group LLP Reports
11. Federal Judge Orders Updated Accounting in Bard Avaulta Vaginal Mesh Lawsuits, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: